| Patent application number | Description | Published |
|---|
| 20090018054 | Cholesteryl Ester Transfer Protein Inhibitors - Compounds of Formula (I), including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In the compounds of Formula (I), A | 01-15-2009 |
| 20090042892 | Cetp Inhibitors - Compounds having the structure of Formula (I), including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In the compounds of Formula (I), B is a cyclic group other than phenyl, and B has a cyclic substituent at a position that is ortho to the position at which B is connected to the remainder of the structure of Formula (I). The 5-membered ring of Formula (I) has a second cyclic substituent in addition to B. | 02-12-2009 |
| 20090075979 | CETP Inhibitors - Compounds having the structure of Formula (I), including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In the compounds of Formula (I), B or R | 03-19-2009 |
| 20090137548 | 1,3-Oxazolidin-2-One Derivatives Useful as Cetp Inhibitors - Compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. The compounds have 3 cyclic groups connected by single bonds, as for example triphenyl, which are attached directly to the ring of formula I or attached at the position B. | 05-28-2009 |
| 20090264405 | Cetp Inhibitors - Compounds of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. | 10-22-2009 |
| 20090306202 | D-homoandrosta-17-yl carbamate derivatives as selective glucocorticoid receptor ligands - The present invention is directed to D-homoandrosta-17-yl-carbamate derivatives as selective glucocorticoid receptor ligands useful for treating a variety of autoimmune and inflammatory diseases or conditions. Pharmaceutical compositions and methods of use are also included. | 12-10-2009 |
| 20100029678 | DIURETICS - A compound having the structure | 02-04-2010 |
| 20100099716 | CETP INHIBITORS - Compounds having the structures of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis: | 04-22-2010 |
| 20100144810 | ANGIOTENSIN II RECEPTOR ANTAGONISTS - A compound having the structure | 06-10-2010 |
| 20100152258 | ANGIOTENSIN II RECEPTOR ANTAGONISTS - A compound having the structure (Formula I), wherein Y is —Y | 06-17-2010 |
| 20100152259 | ANGIOTENSIN II RECEPTOR ANTAGONISTS - A compound having the structure (Formula I), wherein R an angiotensin receptor antagonist active group, Y is Y | 06-17-2010 |
| 20100167986 | Cholesteryl Ester Transfer Protein Inhibitors - Compounds of Formula (I), including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In the compounds of Formula (I), A | 07-01-2010 |
| 20100249024 | CETP INHIBITORS - Compounds of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In the compounds of Formula 1, A | 09-30-2010 |
| 20100273845 | ANGIOTENSIN II RECEPTOR ANTAGONISTS - A compound having the structure | 10-28-2010 |
| 20100292192 | ANGIOTENSIN II RECEPTOR ANTAGONISTS - A compound having the structure | 11-18-2010 |
| 20100298277 | ANGIOTENSIN II RECEPTOR ANTAGONISTS - A compound having the structure | 11-25-2010 |
| 20110065765 | ANGIOTENSIN II RECEPTOR ANTAGONISTS - A compound having the structure | 03-17-2011 |
